EN
HI
Bacil Pharma Share price
BACPHAR
12.3
0.44 (3.71%)Last updated on 21 Aug, 2026 | 16:01 IST
Free Demat with Zero AMC*
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
Bacil Pharma share price chart
Bacil Pharma Share Key Metrics
Volume
66647.00
Market Cap
7.24 CR
LTQ@LTP
500@12.30
ATP
12.37
Var Margin
50 %
Circuit Range
11.69-12.91
Delivery %
75.6 %
Value
8.24 L
ASM/GSM
No
Market Lot
1
Summary
BACPHAR stock price is ₹12.3 as of 22 Aug, 2026. The stock intraday movement has stayed between ₹12.05 and ₹12.45, while Bacil Pharma share price 52 week high low is ₹11.00 & ₹61.80.
In terms of trading activity, BACPHAR share price has recorded a volume of 66,647 shares. The Bacil Pharma has a market cap of ₹5890000. The stock’s Average Traded Price (ATP) stands at ₹12.37, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 500 @ ₹12.30.
The Bacil Pharma upper circuit limit is ₹12.91 & The Bacil Pharma lower circuit limit is ₹11.69, with a Value of ₹8.24 L. The Delivery Percentage for the day is 75.6%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Bacil Pharma Resistance and Support
Pivot 11.57
Resistance
First Resistance
12.14
Second Resistance
12.43
Third Resistance
13
Support
First Support
11.28
Second Support
10.71
Third Support
10.42
Bacil Pharma Shareholding Pattern
View More- 2016-17
- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Segment
Percent
Total Promoters
0%
Mutual Fund
0%
Insurance
0%
Foreign Institutional Investors
0%
Domestic Institutional Investors
0%
Retail
100%
Others
0%
Total Promoters
MAR '26
0%
JUN '26
0%
Bacil Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-25 | Others |
| 2026-08-12 | Quarterly Results |
| 2026-07-09 | Others |
| 2026-06-26 | Fund Raising & Others |
| 2026-05-22 | Audited Results |
| 2026-02-13 | Quarterly Results |
| 2025-11-13 | Quarterly Results |
| 2025-09-05 | Others |
| 2025-08-25 | Others |
| 2025-08-12 | Quarterly Results |
| 2025-07-16 | Others |
| 2025-05-26 | Audited Results |
| 2025-01-21 | Quarterly Results |
| 2024-10-23 | Quarterly Results |
| 2024-10-15 | Others |
| 2024-09-27 | Increase in Authorised Capital |
| 2024-08-14 | Quarterly Results |
Bacil Pharma News
Bacil Pharma Ltd - 524516 - Board Meeting Outcome for Outcome Of Board Meeting Held On 12Th August, 2026
Bacil Pharma reported a steep decline in Q1 FY27 performance. Revenue fell 91.1% YoY to ₹8.91 lakhs, and net profit for the period dropped 55% YoY to ₹30.12 lakhs, mainly due to an operational loss of ₹1.61 lakhs.
Aug 12 2026 16:13:36
Bacil Pharma Ltd - 524516 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 12Th August 2026
Bacil Pharma's Board of Directors is scheduled to meet on August 12, 2026. The primary agenda is the consideration and approval of the unaudited financial results for the quarter ended June 30, 2026, providing an update on the company's recent performance.
Aug 06 2026 19:32:27
Bacil Pharma Ltd - 524516 - Announcement Under Regulation 30, LODR
Bacil Pharma has incorporated a wholly-owned subsidiary, Bacil Research & Development Private Limited, on July 28, 2026. This new entity is expected to drive the company's innovation and expansion into new business verticals within the healthcare sector.
Jul 28 2026 18:31:33
Read More
Bacil Pharma Management
| Name | Position |
|---|---|
| Dinesh Chander Notiyal | Non Executive Independent Director |
| Avani Savjibhai Godhaniya | Non Executive Independent Director |
Bacil Pharma FAQs
The Buying Price of Bacil Pharma share is 12.3 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Bacil Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Bacil Pharma, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Bacil Pharma shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Bacil Pharma shares is 0. Useful to assess the stock's value relative to its book value.
To assess Bacil Pharma’s valuation compare Sector P/E, P/B which are 68.51 & 3.35 with sector averages, along with growth rates and financial metrics.
The Market Cap of Bacil Pharma is 7.24 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Bacil Pharma share price is 61.80 & 11.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Bacil Pharma belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in BACPHAR
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC